|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Juno Therapeutics, Inc.
| | | Phone: | (206) 582-1600 | Year Established: | 2013 | Ticker: | CELG | Exchange: | NASDAQ | Main Contact: | Hans Bishop, President & CEO | | Other Contacts: | Ann L. Lee, Executive VP, Technical Operations Andy Walker, Ph.D., Senior VP, Manufacturing Robin Andrulevich, VP, People Robert Azelby, Executive VP & CCO Corsee D. Sanders, Executive VP & Head of Development Operations Barney Cassidy, J.D., General Counsel & Secretary Elizabeth Smith, Senior VP, Regulatory & Quality Assurance Mark Gilbert, M.D., Senior VP & CMO Hyam Levitsky, M.D., Executive VP & CSO Mark Frohlich, M.D., Executive VP, Development & Portfolio Strategy Steve Harr, M.D., CFO & Head of Corporate Development Sunil Agarwal, President, R&D
| | Company Description | Juno, a Celgene subsidiary, is a clinical stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of potential curative immunotherapy treatments. | |
|
|
|
|
|